
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.
CleanTech Lithium PLC
("CleanTech Lithium" or the "Company")
Results of Broker Option
26 August 2025 - CleanTech Lithium PLC (AIM: CTL), an exploration and development company advancing sustainable lithium projects in Chile, is pleased to announce that, further to the announcement on 11 August 2025, the broker option granted to Fox-Davies Capital Limited to deal with any additional demand from existing institutional shareholders who did not have the opportunity to participate in the Placing (the "Broker Option") has been exercised in respect of 8,000,000 new ordinary shares at the Issue Price (the "Broker Option Shares"). The Broker Option was for £250,000 with a possibility of being increased at Fox-Davies and the Company's discretion. Given the additional demand it was upsized to £400,000 and remains conditional on shareholder approval at the general meeting of the Company to be held at 10:00 a.m. on 29 August 2025 (the "General Meeting").
The Broker Option has conditionally raised gross proceeds of £400,000 which will be in addition to the £4.3 million raised pursuant to the Placing. As announced 11 August 2025, the Company also intends to conduct a retail offer to existing shareholders, details of which will be announced shortly.
The Broker Option Shares carry a warrant entitlement of one warrant for every Broker Option Share. Each warrant grants the holder the right to subscribe for one new ordinary share at a price of 6 pence, being at a 20% per cent premium to the Issue Price. The Broker Option is subject to shareholder approval at the General Meeting.
Capitalised terms used but not defined in this announcement shall have the meaning given to them in the Company's announcement of the Fundraising on 11 August 2025.
Steve Kesler, Non-Executive Chairman of CleanTech Lithium, said:
"Following the recent successful fundraising, the Broker Option allowed additional participation on the same terms, enabling existing institutional investors to further demonstrate their support and confidence in CleanTech Lithium. Thank you to the investors who participated. This result strengthens our capital base as we advance the Laguna Verde project, following the acquisition of the Minergy licences which has positioned us more favourably for the CEOL application.
Over the coming months, our focus is on completing the PFS for Laguna Verde, progressing our CEOL application which in turn will help initiate strategic investor conversations."
Upcoming General Meeting
The Broker Option is subject to shareholder approval at the General Meeting, further details of which are set out in a shareholder circular published by the Company on 13 August 2025, which is available on the Company's website https://ctlithium.com/investors/circulars-documents/.
Admission and Trading
Subject to approval being given at the General Meeting, application has been made to London Stock Exchange for the Broker Option Shares (together with the Conditional Placing Shares) to be admitted to trading on AIM ("Second Admission"). It is currently expected that Second Admission will become effective, and trading of the Broker Option Shares (together with the Conditional Placing Shares) will commence on AIM, at 8.00 a.m. on 1 September 2025.
The Broker Option Shares (as well as the Conditional Placing Shares) will, when issued, be credited as fully paid and will rank pari passu in all respects with the existing ordinary shares of the Company, including the right to receive all dividends or other distributions made, paid or declared in respect of such shares after the date of issue of the Broker Option Shares (as well as the Conditional Placing Shares).
For further information contact: |
|
CleanTech Lithium PLC |
|
Ignacio Mehech/Gordon Stein/Nick Baxter |
Office: +44 (0) 1534 668 321 Mobile: +44 (0) 7494 630 360 Chile office: +562-32239222 |
Beaumont Cornish Limited (Nominated Adviser) Roland Cornish/Asia Szusciak |
+44 (0) 20 7628 3396 |
Fox-Davies Capital Limited (Broker and Bookrunner) Daniel Fox-Davies |
+44 (0) 20 3884 8450 |
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this inside information is now considered to be in the public domain. The person who arranged for the release of this announcement on behalf of the Company was Steve Kesler, Director and Chairman.
The distribution of this announcement and the offering of the Broker Option Shares in certain jurisdictions may be restricted by law. No action has been taken by the Company or the Bookrunner that would permit an offering of such shares or possession or distribution of this announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company and the Bookrunner to inform themselves about, and to observe, any such restrictions.
This announcement is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into Australia, Canada, Japan or the Republic of South Africa or any jurisdiction into which the publication or distribution would be unlawful. This announcement is for information purposes only and does not constitute an offer to sell or issue or the solicitation of an offer to buy or acquire shares in the capital of the Company in Australia, Canada, Japan, New Zealand, the Republic of South Africa or any jurisdiction in which such offer or solicitation would be unlawful or require preparation of any prospectus or other offer documentation or would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction.
This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.
Fox-Davies Capital Limited is authorised and regulated by the FCA in the United Kingdom and is acting as Bookrunner for the Company and no one else in connection with the Placing and the Broker Option and will not be responsible to anyone (including any Places) other than the Company for providing the protections afforded to its clients or for providing advice in relation to the Placing or the Broker Option or any other matters referred to in this announcement.
Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser to the Company in relation to the Placing and the Broker Option and is not acting for any other persons in relation to the Placing and the Broker Option. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.
**ENDS**
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.